Cutia Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	265.01	385.67	473.12	465.87	203.13
Short-Term Investments	91.75	10.53	330.19	567.15	769.65
Trading Asset Securities	431.49	479.96	469.34	43.5	405.49
Cash & Short-Term Investments	788.24	876.16	1,273	1,077	1,378
Cash Growth	-10.03%	-31.16%	18.22%	-21.89%	-
Accounts Receivable	183.3	100.53	63.5	1.34	0.5
Other Receivables	-	4.22	13.47	2.78	0
Receivables	183.3	104.75	76.97	4.12	0.5
Inventory	35.46	74.69	45.31	20	1.8
Restricted Cash	0.59	-	-	-	-
Other Current Assets	35.06	31.53	21.38	44.8	21.15
Total Current Assets	1,043	1,087	1,416	1,145	1,402
Property, Plant & Equipment	204.81	220.93	226.01	229.01	50.79
Other Intangible Assets	8.14	8.9	7.81	0.6	0.22
Long-Term Accounts Receivable	36.24	8.61	9.97	11.27	4.03
Other Long-Term Assets	14.45	34.41	14.95	30.23	26.86
Total Assets	1,306	1,393	1,707	1,447	1,495
Accounts Payable	15.36	12.82	20.29	-	0.34
Accrued Expenses	22.21	32.96	34.84	17.88	12.19
Short-Term Debt	97.88	173.3	89.41	-	-
Current Portion of Long-Term Debt	68.76	40	40	-	-
Current Portion of Leases	15.56	12.38	11.37	8.83	3.72
Current Income Taxes Payable	7.22	6.57	1.34	0.96	0.63
Current Unearned Revenue	-	-	0.4	-	-
Other Current Liabilities	42.73	45.23	57.13	49.73	2.39
Total Current Liabilities	269.72	323.25	254.79	77.4	19.25
Long-Term Debt	84.57	50	60	2,570	2,243
Long-Term Leases	50.63	45.26	42.97	45.3	22.82
Long-Term Unearned Revenue	16.09	-	-	0.4	0.4
Total Liabilities	421	418.51	357.76	2,693	2,285
Common Stock	0.05	0.05	0.04	0.01	0.01
Additional Paid-In Capital	-	4,691	4,686	259.16	259.16
Retained Earnings	-	-3,384	-2,950	-986.11	-430.28
Treasury Stock	-13.86	-13.86	-	-	-
Comprehensive Income & Other	899.09	-318.41	-387.02	-519.37	-619.4
Shareholders' Equity	885.28	974.73	1,349	-1,246	-790.51
Total Liabilities & Equity	1,306	1,393	1,707	1,447	1,495
Total Debt	317.39	320.94	243.76	2,624	2,269
Net Cash (Debt)	470.85	555.22	1,029	-1,548	-891.19
Net Cash Growth	-15.20%	-46.04%	-	-	-
Net Cash Per Share	1.42	1.81	5.03	-19.33	-11.13
Filing Date Shares Outstanding	342.94	318.59	304.02	80.05	80.05
Total Common Shares Outstanding	342.94	318.59	304.02	80.05	80.05
Working Capital	772.94	763.87	1,162	1,068	1,382
Book Value Per Share	2.58	3.06	4.44	-15.57	-9.88
Tangible Book Value	877.15	965.84	1,341	-1,247	-790.73
Tangible Book Value Per Share	2.56	3.03	4.41	-15.58	-9.88
Machinery	-	89.89	74.31	52.9	19.38
Construction In Progress	-	3.11	2.48	7.23	0.03
Leasehold Improvements	-	156.31	148.69	136.38	13.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.